Canada Pension Plan Investment Board’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-65,000
Closed -$11.7M 1266
2017
Q3
$11.7M Buy
+65,000
New +$9.06M 0.02% 478
2016
Q4
Sell
-1,400
Closed -$78K 1162
2016
Q3
$78K Buy
+1,400
New +$78K ﹤0.01% 1035

Canada Pension Plan Investment Board's KITE Position: Q4 2017 in Review

Canada Pension Plan Investment Board sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 65,000 shares — an estimated $11.7M sold.

Canada Pension Plan Investment Board first reported a position in KITE in Q3 2016 and held it in 2 quarters. The position peaked at $11.7M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Canada Pension Plan Investment Board reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 65,000 Kite Pharma, Inc. shares in Q4 2017, an estimated $11.7M.
  • Canada Pension Plan Investment Board first reported a position in Kite Pharma, Inc. in Q3 2016 and held it in 2 quarters.
  • Canada Pension Plan Investment Board's Kite Pharma, Inc. position peaked at $11.7M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Canada Pension Plan Investment Board's 13F filing for Q4 2017, filed 14 Feb 2018.